Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic()

The COVID-19 pandemic and the move to telemedicine for office-based opioid treatment have made the practice of routine urine drug tests (UDT) obsolete. In this commentary we discuss how COVID-19 has demonstrated the limited usefulness and possible harms of routine UDT. We propose that practitioners...

Descripción completa

Detalles Bibliográficos
Autores principales: Pytell, Jarratt D., Rastegar, Darius A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534596/
https://www.ncbi.nlm.nih.gov/pubmed/33298297
http://dx.doi.org/10.1016/j.jsat.2020.108155
Descripción
Sumario:The COVID-19 pandemic and the move to telemedicine for office-based opioid treatment have made the practice of routine urine drug tests (UDT) obsolete. In this commentary we discuss how COVID-19 has demonstrated the limited usefulness and possible harms of routine UDT. We propose that practitioners should stop using routine UDT and instead use targeted UDT, paired with clinical reasoning, as part of a patient-centered approach to care.

Ejemplares similares